Transition to continuous trading

Novacyt (ISIN Code: FR0010397232 – Mnemonic code: ALNOV), an international specialist in cancer and infectious disease diagnostics, today announces that its stock will transition to continuous trading starting 15th of December 2014. Download press release

Visit Page

Novacyt announces a €3.1M capital raise and prepares for new market launches

Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, today announces a private equity placement financing of €3.1m. Download press release

Visit Page

Novacyt announces 2014 Half Year Results and updates strong progress with integration of Lab21

Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, today announces its half year results for the six months ended 30th June 2014 approved by the Board of Directors on 28th October 2014. Novacyt also provides an update on the progress of the recent integration of Lab21. Download press release

Visit Page